Cergentis is a genomics-focused biotechnology company and leading provider of genetic quality control solutions, based on its proprietary Targeted Locus Amplification (TLA) technology platform. With our widely published and recognized genetic analyses, we support all leading pharma companies and research institutes in the characterization and QC of their genetically engineered (animal) models, biopharmaceutical cell line development, and cell and gene therapy products. By helping our customers to de-risk R&D program decisions, minimizing time-to-clinic, providing objective genomic evidence to regulators, and supporting patient safety, we aim to support biopharmaceutical medicine programs worldwide.

In July 2022, Cergentis became part of the Solvias Group.

Cergentis B.V.

Cergentis is a genomics-focused biotechnology company and leading provider of genetic quality control solutions, based on its proprietary Targeted Locus Amplification (TLA) technology platform. With our widely published and recognized
Adres
Alexander Numangebouw, Yalelaan 62, 3584 CM Utrecht, Nederland
Website
https://www.cergentis.com
E-mail
info@cergentis.com
Telefoon
+31 (0)30 760 16 36